Upgrade to Pro — share decks privately, control downloads, hide ads and more …

Monepantel Resistance

Avatar for Uni of Nomi Uni of Nomi
February 07, 2024

Monepantel Resistance

The following presentation is based on this paper, which looked at the mode of action of monepantel, an anthelmintic drug, on parasitic drug targets:

Baur, R., Beech, R., Sigel, E., & Rufener, L. (2015). Monepantel irreversibly binds to and opens Haemonchus contortus MPTL-1 and Caenorhabditis elegans ACR-20 receptors. Molecular pharmacology, 87(1), 96–102. https://doi.org/10.1124/mol.114.095653

https://pubmed.ncbi.nlm.nih.gov/25352042/

Monepantel Resistance © 2021 by E. Nomi is licensed under CC BY-NC-SA 4.0

Avatar for Uni of Nomi

Uni of Nomi

February 07, 2024
Tweet

More Decks by Uni of Nomi

Other Decks in Science

Transcript

  1. References Baur, R., Beech, R. N., Sigel, E., & Rufener,

    L. (2014). Monepantel Irreversibly Binds to and Opens Haemonchus contortus MPTL-1 and Caenorhabditis elegans ACR-20 Receptors. Molecular Pharmacology, 87(1), 96–102. https://doi.org/10.1124/mol.114.095653 James, C., Hudson, A. L., & Davey, M. W. (2009). Drug resistance mechanisms in helminths: is it survival of the fittest? Trends in Parasitology, 25(7), 328–335. https://doi.org/10.1016/j.pt.2009.04.004 Lecová, L., Stuchlíková, L. R., Prchal, L., & Skálová, L. (2014). Monepantel: the most studied new anthelmintic drug of recent years. Parasitology, 141(13), 1686–1698. https://doi.org/10.1017/s0031182014001401